AKTX
Akari Therapeutics
AKTX
AKTX
15 hedge funds and large institutions have $4.19M invested in Akari Therapeutics in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
34% less capital invested
Capital invested by funds: $6.37M → $4.19M (-$2.18M)
Holders
15
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$8.6K | |
| 2 | +$7.57K | |
| 3 | +$7.22K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$6.31K |
| 5 |
LPL Financial
San Diego,
California
|
+$5.45K |
Top Sellers
| 1 | -$385K | |
| 2 | -$204K | |
| 3 | -$13K | |
| 4 |
TC
Truvestments Capital
Sarasota,
Florida
|
-$293 |